Are you sure about that? You seem to be judging BLG by it's P&L. This makes no sense for a company still in R&D phase. The primary performance criterion ATM is the trajectory of the R&D that they are undertaking. Whether or not this R&D leads to commercialization, production at scale, and nett profit, is the gamble we are taking investing in this stock. If the company successfully makes the transition, then by the time it becomes apparent to all that it is underway, the opportunity to 'buy the dip' will be long gone.
There is also the possibility of a takeover bid (the company is an easy target at current SP), in which case the re-rating will be virtually instantaneous.
All IMO.
BLG Price at posting:
2.3¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)